13 results
424B4
DRMA
Dermata Therapeutics Inc
13 May 22
Prospectus supplement with pricing info
5:06pm
standards; federal, state and foreign healthcare fraud and abuse laws and data privacy; or laws that require the true, complete and accurate reporting
10-K
2021 FY
DRMA
Dermata Therapeutics Inc
28 Mar 22
Annual report
8:33am
to the FDA or foreign regulatory authorities; manufacturing standards; federal, state and foreign healthcare fraud and abuse laws and data privacy; or laws
DRS
pb45610zayv e3
11 Jan 22
Draft registration statement
12:00am
424B4
ng418y af566jcf75
16 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1
jm67xkkn8nm d9
10 Jun 21
IPO registration
5:11pm
DRS/A
24k1lwzg6cy78p 469eg
7 May 21
Draft registration statement (amended)
12:00am
DRS
w1s4n8y91zr izvk
2 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next